REDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AFTER SWITCH FROM DUAL THERAPY TO SINGLE-INHALER TRIPLE THERAPY IN A REAL-WORLD HEALTH CARE SETTING IN THE US

被引：0
|
作者：
McCormack, Meredith C.
Noorduyn, Stephen G.
Gronroos, Noelle
Lee, Lydia
Johnson, Mary
Wrobleski, Kristin
Veeranki, Phani
Ismaila, Afisi S.
Igboekwe, Emmeline
Paczkowski, Rosirene
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3204
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4942A / 4943A
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of single-inhaler triple therapy for chronic obstructive pulmonary disease treatment by baseline blood eosinophil count: IMPACT trial
    Shah, Dhvani
    Martin, Alan
    Kendall, Robyn
    Risebrough, Nancy
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [42] Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Improves Lung Function and Symptoms Compared with Tiotropium Monotherapy in Patients with Symptomatic Chronic Obstructive Pulmonary Disease at Risk of Exacerbations
    Obeid, D.
    Bansal, S.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Erb, D.
    Harvey, C.
    Kaisermann, M. C.
    Kaye, M.
    Lipson, D. A.
    Martin, N.
    Zhu, C. Q.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] Analysis of Chronic Obstructive Pulmonary Disease Exacerbations With the Triple Therapy Compared With Dual and Single Bronchodilator Therapy: Which Treatment Is Better for Patients With Severe Disease?
    Sadigov, Alizamin
    Akhundov, Sakhavatdin
    Bagirov, Rovshan
    CHEST, 2014, 145 (03)
  • [44] Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety
    Suissa, Samy
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (03)
  • [45] Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease
    Singh, Dave
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1279 - 1287
  • [46] Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study
    Rothnie, Kieran J.
    Wood, Robert P.
    Czira, Alexandrosz
    Banks, Victoria L.
    Camidge, Lucinda J.
    Massey, Olivia K., I
    Seif, Monica
    Compton, Chris
    Sharma, Raj
    Halpin, David M. G.
    Ismaila, Afisi S.
    Vogelmeier, Claus F.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [47] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
  • [48] TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    RESPIRATORY MEDICINE, 2021, 182
  • [49] Comparative Effectiveness of Triple Therapy versus Dual Bronchodilation in Elder Adults with Chronic Obstructive Pulmonary Disease (COPD): A Real-World Population Study
    Gershon, A. S.
    Jiang, L.
    Kendzerska, T.
    Tan, W.
    Stukel, T.
    Stanbrook, M. B.
    Aaron, S. D.
    Pequeno, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] Role Of Inhaled Corticosteroid Therapy In The Real-World Management Of Chronic Obstructive Pulmonary Disease
    Postma, D.
    Colice, G.
    Martin, R.
    Barnes, N.
    Roche, N.
    Lee, A. J.
    Dorinsky, P.
    Burden, A.
    von Ziegenweidt, J.
    Hillyer, E. V.
    Chisholm, A.
    Price, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
12345